TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nord Vacc Läkemedel AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
7,359
|
6,451
|
4,645 |
Financial expenses |
105
|
12
|
35 |
Earnings before taxes |
-10,240
|
-750
|
-3,059 |
EBITDA |
-10,098
|
-1,028
|
-2,869 |
Total assets |
5,100
|
8,563
|
4,888 |
Current assets |
5,056
|
6,838
|
3,072 |
Current liabilities |
1,841
|
1,438
|
3,276 |
Equity capital |
320
|
565
![]() |
565 |
- share capital |
471
![]() |
471
![]() |
471 |
Employees (average) |
2
|
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
6.3%
|
6.6%
|
11.6% |
Turnover per employee |
3,680
|
2,150
|
1,548 |
Profit as a percentage of turnover |
-139.1%
|
-11.6%
|
-65.9% |
Return on assets (ROA) |
-198.7%
|
-8.6%
|
-61.9% |
Current ratio |
274.6%
|
475.5%
|
93.8% |
Return on equity (ROE) |
-3200%
|
-132.7%
|
-541.4% |
Change turnover |
908
|
1,806
|
844 |
Change turnover % |
14%
|
39%
|
22% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-33%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.